These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 7709160)

  • 41. Re-Appraisal of Estrogen Receptor Negative/Progesterone Receptor Positive (ER-/PR+) Breast Cancer Phenotype: True Subtype or Technical Artefact?
    Foley NM; Coll JM; Lowery AJ; Hynes SO; Kerin MJ; Sheehan M; Brodie C; Sweeney KJ
    Pathol Oncol Res; 2018 Oct; 24(4):881-884. PubMed ID: 28891017
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Demonstration of estrogen and progesterone receptors in breast cancers with monoclonal antibodies. Different results with enzyme-immunoassay and immunohistochemical methods.
    Mink D; Hollaender M; von Tongelen B; Villena-Heinsen C; Schmidt W
    Eur J Gynaecol Oncol; 1995; 16(2):81-91. PubMed ID: 7641743
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Comparison of monoclonal immunocytochemical and immunoenzymatic methods for steroid receptor evaluation in breast cancer.
    De Negri F; Campani D; Sarnelli R; Martini L; Gigliotti A; Bonacci R; Fabbri R; Squartini F; Pinchera A; Giani C
    Am J Clin Pathol; 1991 Jul; 96(1):53-8. PubMed ID: 2069136
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [A comparative study of hormone receptors in breast cancer with quantitative immunocytochemistry and biochemistry].
    Marcot I; Migeon C; Parache RM; Marchal S; Virion JM
    Bull Cancer; 1997 Jun; 84(6):613-8. PubMed ID: 9295864
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Absence of progesterone receptor associated with secondary breast cancer in postmenopausal women.
    Balleine RL; Earl MJ; Greenberg ML; Clarke CL
    Br J Cancer; 1999 Mar; 79(9-10):1564-71. PubMed ID: 10188907
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Estrogen & progesterone receptors measurement in breast cancer with enzyme-immunoassay & correlation with other prognostic factors.
    Redkar AA; Kabre SS; Mittra I
    Indian J Med Res; 1992 Feb; 96():1-8. PubMed ID: 1597324
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Correlation of steroid receptors in synchronous tissues with survival in breast cancer patients.
    Bhatavdekar JM; Patel DD; Karelia NH; Suthar TP; Shah NG; Vora HH; Ghosh N; Nadkarni SP; Balar DB
    Neoplasma; 1993; 40(3):177-80. PubMed ID: 8350965
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Determination of threshold values for determining the size of the fraction of steroid hormone receptor-positive tumor cells in paraffin-embedded breast carcinomas.
    Leers MP; Hoop JG; van Beers M; van Rodijnen N; Pannebakker M; Nap M
    Cytometry B Clin Cytom; 2005 Mar; 64(1):43-52. PubMed ID: 15668953
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Immunohistochemical characteristics of mammary carcinomas with estrogen-negative and progesterone-positive receptors].
    Sundblad AS; Caprarulo L
    Medicina (B Aires); 1996; 56(6):683-9. PubMed ID: 9284572
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Comparison of an immunocytochemical assay for progesterone receptor with a biochemical method of measurement and immunocytochemical examination of the relationship between progesterone and estrogen receptors.
    Berger U; Wilson P; Thethi S; McClelland RA; Greene GL; Coombes RC
    Cancer Res; 1989 Sep; 49(18):5176-9. PubMed ID: 2766287
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Comparison of immunohistochemistry with PCR for assessment of ER, PR, and Ki-67 and prediction of pathological complete response in breast cancer.
    Sinn HP; Schneeweiss A; Keller M; Schlombs K; Laible M; Seitz J; Lakis S; Veltrup E; Altevogt P; Eidt S; Wirtz RM; Marmé F
    BMC Cancer; 2017 Feb; 17(1):124. PubMed ID: 28193205
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Association between HER-2/neu and the progesterone receptor in oestrogen-dependent breast cancer is age-related.
    Huang HJ; Neven P; Drijkoningen M; Paridaens R; Wildiers H; Van Limbergen E; Berteloot P; Amant F; Christiaens MR; Vergote I
    Breast Cancer Res Treat; 2005 May; 91(1):81-7. PubMed ID: 15868434
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Hormonal receptors in locally advanced breast cancer: change with response to neoadjuvant chemotherapy?
    Morris DM; Edwards J; Gelder F
    J Surg Oncol; 1991 Mar; 46(3):156-8. PubMed ID: 2011025
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Correlation of immunocytochemical and immunohistochemical determination of estrogen and progesterone receptors in breast cancer.
    Zoppi JA; Rotundo AV; Sundblad AS
    Acta Cytol; 2002; 46(2):337-40. PubMed ID: 11917582
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Immunohistochemical analysis of estrogen and progesterone receptor and neu expression in breast carcinoma.
    Chu JS; Lee WJ; Chen KM; Hsu HC
    J Formos Med Assoc; 1994 Apr; 93(4):277-82. PubMed ID: 7914767
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Comparing breast biomarker status between routine immunohistochemistry and FISH studies and Oncotype DX testing, a study of 610 cases.
    Neely C; You S; Mendoza PM; Aneja R; Sahin AA; Li X
    Breast J; 2018 Nov; 24(6):889-893. PubMed ID: 30230095
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Significance of the 8S complex in oestrogen receptor recognition.
    Marsigliante S; Puddefoot JR; Barker S; Goode AW; Vinson GP
    J Steroid Biochem Mol Biol; 1991 Nov; 39(5A):703-11. PubMed ID: 1958507
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Determination of estrogen and progesterone receptors in human breast cancer cytosols: a comparison between radioligand binding assay (DCC) and enzyme immunoassay (EIA).
    Cerra M; Cecco L; Montella M; Celentano E; Bonelli P; Tuccillo F
    Int J Biol Markers; 1996; 11(1):50-2. PubMed ID: 8740643
    [No Abstract]   [Full Text] [Related]  

  • 59. Immunoreactive prostate-specific antigen levels in female and male breast tumors and its association with steroid hormone receptors and patient age.
    Yu H; Diamandis EP; Sutherland DJ
    Clin Biochem; 1994 Apr; 27(2):75-9. PubMed ID: 7520846
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Progesterone receptors in normal, dysplastic and tumourous feline mammary glands. Comparison with oestrogen receptors status.
    Martín de las Mulas J; Van Niel M; Millán Y; Ordás J; Blankenstein MA; Van Mil F; Misdorp W
    Res Vet Sci; 2002 Apr; 72(2):153-61. PubMed ID: 12027597
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.